Iande Boer SeattleUnited States

Wcn26 Post edited Speaker Card

Time	Session

5 p.m. 6 p.m.	Industry Symposium 59 TakashiYokoo Chair tyokoo@jikei.ac.jpJapan From Evidence to Practice: SGLT2Inhibitors as a Foundational Treatment for Patients With CKD BeatrizFernandez-Fernandez Speaker bfernandez@fjd.esSpain Prompt Action in CKD: Increasing Treatment Benefits for Your Patients With CKD Iande Boer Speaker deboer@uw.eduUnited States The Hidden Burden: Managing Cardiovascular Disease in Patients With CKD BrendonNeuen Speaker bneuen@georgeinstitute.org.auAustralia 301 - 302

Time

Session

5 p.m.

6 p.m.

Industry Symposium 59

TakashiYokoo Chair tyokoo@jikei.ac.jpJapan

301 - 302